Anti-carbamylated-FCS IgG and IgA antibodies are present in both anti-CCP negative (IgG: 16%, IgA: 30%) and anti-CCP positive (IgG: 73%, IgA: 51%) RA patients [9]. The gene discussed is CD79A; the disease is rheumatoid arthritis.